Eurizon Capital SGR S.p.A. Purchases Shares of 39,586 Nutrien Ltd. $NTR

Eurizon Capital SGR S.p.A. purchased a new stake in shares of Nutrien Ltd. (NYSE:NTRFree Report) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 39,586 shares of the company’s stock, valued at approximately $2,443,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Montag A & Associates Inc. grew its position in Nutrien by 310.7% during the fourth quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock valued at $26,000 after acquiring an additional 320 shares during the period. Eastern Bank grew its position in Nutrien by 133.0% during the fourth quarter. Eastern Bank now owns 699 shares of the company’s stock valued at $43,000 after acquiring an additional 399 shares during the period. Harbour Investments Inc. grew its position in Nutrien by 97.2% during the fourth quarter. Harbour Investments Inc. now owns 704 shares of the company’s stock valued at $43,000 after acquiring an additional 347 shares during the period. Geneos Wealth Management Inc. grew its position in Nutrien by 42.4% during the second quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock valued at $43,000 after acquiring an additional 219 shares during the period. Finally, Fulcrum Asset Management LLP purchased a new stake in Nutrien during the third quarter valued at about $46,000. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien Price Performance

Shares of NYSE NTR opened at $68.55 on Wednesday. Nutrien Ltd. has a 1-year low of $53.03 and a 1-year high of $85.36. The business has a 50-day moving average of $72.77 and a 200-day moving average of $68.63. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.24 and a quick ratio of 0.59. The company has a market capitalization of $32.90 billion, a price-to-earnings ratio of 13.96, a PEG ratio of 0.64 and a beta of 0.60.

Nutrien (NYSE:NTRGet Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.48 by $0.03. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The business had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $5.30 billion. During the same quarter in the previous year, the firm posted $0.11 earnings per share. The company’s revenue was up 18.5% compared to the same quarter last year. On average, equities analysts anticipate that Nutrien Ltd. will post 5.45 EPS for the current fiscal year.

Nutrien Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 17th. Investors of record on Tuesday, June 30th will be paid a $0.55 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.20 annualized dividend and a dividend yield of 3.2%. Nutrien’s payout ratio is 44.81%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Canadian Imperial Bank of Commerce decreased their price objective on shares of Nutrien from $90.00 to $88.00 and set an “outperformer” rating for the company in a research note on Thursday, April 30th. Barclays raised their target price on shares of Nutrien from $70.00 to $80.00 and gave the company an “equal weight” rating in a research note on Tuesday, March 3rd. Zacks Research lowered shares of Nutrien from a “strong-buy” rating to a “hold” rating in a report on Monday, March 2nd. Scotiabank increased their price target on Nutrien from $75.00 to $80.00 and gave the company a “sector perform” rating in a report on Monday, May 11th. Finally, BNP Paribas Exane lowered Nutrien from an “outperform” rating to a “neutral” rating in a research report on Monday, February 23rd. Eleven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $82.75.

View Our Latest Report on NTR

Nutrien Profile

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Read More

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.